被 發 現 含 有 未 標 示 西 藥 的 產 品
|
| |
| The United States: Fouzee SugarLin Herbal Formula may be harmful due to hidden drug ingredients metformin and glyburide (English only) |
| |
The US Food and Drug Administration (FDA) is advising consumers not to purchase or use Fouzee SugarLin Herbal Formula, a product promoted and sold as a glucose or blood sugar support supplement on various websites and possibly in some retail stores.
FDA laboratory analysis confirmed that Fouzee SugarLin Herbal Formula contains metformin and glyburide not listed on the product label.
Metformin is the active ingredient in several FDA-approved prescription drugs used to treat type 2 diabetes and is only available with a prescription. Metformin may pose a serious risk to consumers because this ingredient can cause a rare but serious side effect called lactic acidosis (a build-up of lactic acid in the blood) that can cause death if untreated. Symptoms of lactic acidosis include nausea, vomiting, fatigue, body aches, respiratory distress, abdominal pain and fast, deep breathing. Metformin may also cause hypoglycemia when taken together with other medications to lower blood sugar.
Glyburide is the active ingredient in some FDA-approved prescription drugs used to treat type 2 diabetes and is only available with a prescription. Glyburide may pose serious and potentially life-threatening risks to consumers because this ingredient may result in unsafe drops in blood sugar levels (hypoglycemia). Common symptoms of hypoglycemia include fast heartbeat, shaking, sweating, nervousness or anxiety, irritability or confusion, dizziness, drowsiness, headache and hunger. Hypoglycemia may quickly become severe, resulting in seizures, coma or death.
Please refer to the following website in FDA for details:
http://www.fda.gov/drugs/medication-health-fraud/fouzee-sugarlin-herbal-formula-may-be-harmful-due-hidden-drug-ingredients
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Saturday, Dec 7, 2024
Issued at HKT 12:00
|
| |
|
